FERRIPROX MR
Identification of Ferriprox Mr
| No description |
Google image searchProduct monograph
Active ingredient
deferiprone, 1000 MG
DIN: 02536579
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Description: MODIFIED-RELEASE TABLET
Schedule: Prescription
Company: CHIESI CANADA CORP.
Date: 05-JUN-2023
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AC — Iron chelating agents (ATC, ATC/DDD)
- V03AC02 — DEFERIPRONE (ATC/DDD)
